Articles frequently viewed together for PMID: 21111783

Year	Number of Results
2010	1
2011	2
2012	1
2013	2
2014	4
2015	3
2024	0

1

Comment on the contribution by Souayah et al., "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009".

Slade BA, Gee J, Broder KR, Vellozzi C. Slade BA, et al. Vaccine. 2011 Jan 29;29(5):865-6. doi: 10.1016/j.vaccine.2010.11.031. Epub 2010 Nov 25. Vaccine. 2011. PMID: 21111783 No abstract available.

2

Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.

Ojha RP, Jackson BE, Tota JE, Offutt-Powell TN, Singh KP, Bae S. Ojha RP, et al. Hum Vaccin Immunother. 2014;10(1):232-7. doi: 10.4161/hv.26292. Epub 2013 Sep 6. Hum Vaccin Immunother. 2014. PMID: 24013368 Free PMC article.

3

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Grimaldi-Bensouda L, Guillemot D, Godeau B, Bénichou J, Lebrun-Frenay C, Papeix C, Labauge P, Berquin P, Penfornis A, Benhamou PY, Nicolino M, Simon A, Viallard JF, Costedoat-Chalumeau N, Courcoux MF, Pondarré C, Hilliquin P, Chatelus E, Foltz V, Guillaume S, Rossignol M, Abenhaim L; PGRx-AID Study Group. Grimaldi-Bensouda L, et al. J Intern Med. 2014 Apr;275(4):398-408. doi: 10.1111/joim.12155. Epub 2013 Nov 22. J Intern Med. 2014. PMID: 24206418 Free article.

4

Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, Klein NP, Weintraub ES. Gee J, et al. Vaccine. 2011 Oct 26;29(46):8279-84. doi: 10.1016/j.vaccine.2011.08.106. Epub 2011 Sep 9. Vaccine. 2011. PMID: 21907257

5

The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.

Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y. Baker B, et al. Expert Opin Drug Saf. 2015;14(9):1387-94. doi: 10.1517/14740338.2015.1073710. Epub 2015 Jul 28. Expert Opin Drug Saf. 2015. PMID: 26216756 Review.

6

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, Lievano F, Velicer C, Drury R, Kuter BJ. Vichnin M, et al. Pediatr Infect Dis J. 2015 Sep;34(9):983-91. doi: 10.1097/INF.0000000000000793. Pediatr Infect Dis J. 2015. PMID: 26107345 Review.

7

Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013.

Moro PL, Zheteyeva Y, Lewis P, Shi J, Yue X, Museru OI, Broder K. Moro PL, et al. Vaccine. 2015 Jan 15;33(4):519-22. doi: 10.1016/j.vaccine.2014.11.047. Epub 2014 Dec 8. Vaccine. 2015. PMID: 25500173 Free PMC article.

8

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

Angelo MG, Zima J, Tavares Da Silva F, Baril L, Arellano F. Angelo MG, et al. Pharmacoepidemiol Drug Saf. 2014 May;23(5):456-65. doi: 10.1002/pds.3593. Epub 2014 Feb 20. Pharmacoepidemiol Drug Saf. 2014. PMID: 24644078 Free PMC article. Review.

9

Safety of quadrivalent human papillomavirus vaccine administered routinely to females.

Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, Cheetham TC, Liaw KL, Takhar H, Jacobsen SJ. Klein NP, et al. Arch Pediatr Adolesc Med. 2012 Dec;166(12):1140-8. doi: 10.1001/archpediatrics.2012.1451. Arch Pediatr Adolesc Med. 2012. PMID: 23027469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year